|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1160222 |
USP |
4-Cymene 100 mg |
|
676.00 CHF
709.80 €
|
|
|
|
USP-1161000 |
USP |
Cyproheptadine Hydrochloride (HCl) 500 mg |
|
460.00 CHF
483.00 €
|
|
|
|
USP-1161010 |
USP |
Cyproheptadine Related Compound A - 5H-dibenzo[a,d]cycloheptene 40 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1161032 |
USP |
Cyproheptadine Related Compound C - (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) 25 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1161203 |
USP |
Cyromazine 200 mg |
|
480.00 CHF
504.00 €
|
|
|
|
USP-1161509 |
USP |
L-Cysteine Hydrochloride 600 mg |
|
502.67 CHF
527.80 €
|
|
|
|
USP-1161586 |
USP |
Cystine 200 mg |
|
561.33 CHF
589.40 €
|
|
|
|
USP-1162002 |
USP |
Cytarabine 250 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1162126 |
USP |
5'-Cytidylic Acid 500 mg |
|
456.00 CHF
478.80 €
|
|
|
|
USP-1162148 |
USP |
Cytosine 100 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1162239 |
USP |
Dabigatran Etexilate Mesylate 100 mg |
|
1,094.67 CHF
1,149.40 €
|
|
|
|
USP-1162240 |
USP |
Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) 15 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1162262 |
USP |
Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) 15 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1162273 |
USP |
Hexyl Methanesulfonate 50 mg |
|
1,268.00 CHF
1,331.40 €
|
|
|
|
USP-1162308 |
USP |
Dacarbazine 125 mg |
|
385.33 CHF
404.60 €
|
|
|
|
USP-1162320 |
USP |
Dacarbazine Related Compound A - 5-Aminoimidazole-4-carboxamide Hydrochloride 50 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1162330 |
USP |
Dacarbazine Related Compound B - 2-azahypoxanthine monohydrate 50 mg |
|
1,794.67 CHF
1,884.40 €
|
|
|
|
USP-1162400 |
USP |
Dactinomycin 50 mg |
|
1,258.67 CHF
1,321.60 €
|
|
|
|
USP-1162421 |
USP |
Daidzein 25 mg |
|
428.00 CHF
449.40 €
|
|
|
|
USP-1162432 |
USP |
Daidzin 30 mg |
|
1,297.33 CHF
1,362.20 €
|
|
|
|
USP-1162454 |
USP |
Dalfampridine (4-Pyridinamine, 4-Aminopyridine) 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1162487 |
USP |
Dalteparin Sodium - Biologic 300 mg |
|
562.67 CHF
590.80 €
|
|
|
|
USP-1162501 |
USP |
Danazol 200 mg |
|
508.00 CHF
533.40 €
|
|
|
|
USP-1162545 |
USP |
Dalfampridine Related Compound A (25 mg) - (4-Aminopyridine 1-oxide) 25 mg |
|
1,458.67 CHF
1,531.60 €
|
|
|
|
USP-1162556 |
USP |
Dalfampridine Related Compound B (50 mg) - (3,5-Dibromopyridin-4-amine) 50 mg |
|
1,389.33 CHF
1,458.80 €
|
|
|
|
USP-1162567 |
USP |
Dalfampridine Related Compound C (25 mg) - (1,3-Di(pyridin-4-yl)urea) 25 mg |
|
1,389.33 CHF
1,458.80 €
|
|
|
|
USP-1163140 |
USP |
Dantrolene 200 mg |
|
520.00 CHF
546.00 €
|
|
|
|
USP-1163151 |
USP |
Dantrolene Sodium (2,4-Imidazolidinedione, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-, sodium salt, hydrate (2:7)) 100 mg |
|
488.00 CHF
512.40 €
|
|
|
|
USP-1163162 |
USP |
Dantrolene Related Compound A - 5-(4-nitrophenyl)-2-furaldehyde azine 50 mg |
|
1,585.33 CHF
1,664.60 €
|
|
|
|
USP-1163173 |
USP |
Dantrolene Related Compound B - 5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl)semicarbazone 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1163184 |
USP |
Dantrolene Related Compound C (5-(4-Nitrophenyl)furan-2-carbaldehyde) 50 mg |
|
1,572.00 CHF
1,650.60 €
|
|
|
|
USP-1163253 |
USP |
Dapagliflozin Propanediol 100 mg |
|
968.00 CHF
1,016.40 €
|
|
|
|
USP-1163264 |
USP |
Dapagliflozin Related Compound A ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) 15 mg |
|
1,514.67 CHF
1,590.40 €
|
|
|
|
USP-1164008 |
USP |
Dapsone 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1164154 |
USP |
Darunavir Ethanolate 100 mg |
|
920.00 CHF
966.00 €
|
|
|
|
USP-1164165 |
USP |
Darunavir System Suitability Mixture (a mixture of darunavir, darunavir carbamate analog, darunavir carbonate analog and darunavir dicarbamate analog) 15 mg |
|
1,484.00 CHF
1,558.20 €
|
|
|
|
USP-1164200 |
USP |
Darifenacin Hydrobromide (150 mg) ((S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide) 150 mg |
|
1,098.67 CHF
1,153.60 €
|
|
|
|
USP-1164211 |
USP |
Darifenacin Chiral Peak ID Mixture (25 mg) (A mixture containing darifenacin hydrobromide, (S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide [133099-07-7], and about 1% of darifenacin R-isomer, (R)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide) [1092800-15-1] 25 mg |
|
764.00 CHF
802.20 €
|
|
|
|
USP-1164222 |
USP |
Darifenacin Peak ID Mixture - (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) 25 mg |
|
718.67 CHF
754.60 €
|
|
|
|
USP-1164233 |
USP |
Darifenacin Related Compound G (5-(2-Bromoethyl)-2,3-dihydrobenzofuran) 25 mg |
|
1,441.33 CHF
1,513.40 €
|
|
|
|
USP-1164697 |
USP |
Daunorubicinone - ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1164700 |
USP |
Daunorubicin Hydrochloride (HCl) 200 mg |
|
1,409.33 CHF
1,479.80 €
|
|
|
|
USP-1165204 |
USP |
Decitabine 100 mg |
|
920.00 CHF
966.00 €
|
|
|
|
USP-1165215 |
USP |
Decitabine Related Compound A (1-O-Acetyl-3,5-di-O-(4-chlorobenzoyl)-2-deoxy-D-ribofuranose) 25 mg |
|
1,484.00 CHF
1,558.20 €
|
|
|
|
USP-1165226 |
USP |
Decitabine Related Compounds B and C Mixture (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-Beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one) 25 mg |
|
1,484.00 CHF
1,558.20 €
|
|
|
|
USP-1165248 |
USP |
Decitabine Related Compound D (Methyl 4-chlorobenzoate) 25 mg |
|
1,297.33 CHF
1,362.20 €
|
|
|
|
USP-1165259 |
USP |
Decitabine Related Compound E (4-Amino-1-(2-deoxy-alpha-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one) 25 mg |
|
1,484.00 CHF
1,558.20 €
|
|
|
|
USP-1165408 |
USP |
Decoquinate 200 mg |
|
470.67 CHF
494.20 €
|
|
|
|
USP-1165656 |
USP |
Deferasirox 200 mg |
|
790.67 CHF
830.20 €
|
|
|
|
USP-1165667 |
USP |
Deferasirox System Suitability Mixture (A mixture containing Deferasirox, Benzoxazinone analog, Deferasirox ethyl ester, Deferasirox 1,2-isomer, Deferasirox 1,3-isomer and Salicylimide) 20 mg |
|
1,484.00 CHF
1,558.20 €
|
|
